New hope for kids with IBS-C: Long-Term safety trial of tenapanor begins
Symptom relief
ENROLLING_BY_INVITATION
This study looks at the long-term safety of tenapanor, a drug that helps with constipation and stomach pain in children aged 6 to 17 with irritable bowel syndrome with constipation (IBS-C). About 150 kids who finished a previous tenapanor study will take the drug for up to a year…
Phase: PHASE3 • Sponsor: Ardelyx • Aim: Symptom relief
Last updated May 17, 2026 11:36 UTC